# DESCRIPTION

## STATEMENT OF FEDERALLY SPONSORED RESEARCH

- acknowledge government support

## TECHNICAL FIELD

- introduce HCV research area

## BACKGROUND

- describe HCV infection and current treatments
- discuss limitations of current treatments

## SUMMARY

- introduce mammalian cell with plasmid encoding HCV genes
- describe production of replication-competent HCV particles
- describe production of isolated HCV structural proteins
- introduce system for assaying HCV particle entry
- describe method for assaying HCV particle entry
- introduce method for identifying cellular proteins necessary for HCV entry
- describe method for identifying HCV glycoproteins necessary for HCV entry
- introduce method for identifying test compounds effective at blocking HCV entry
- describe other methods for identifying cellular factors and test compounds

## DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS

- define key terms
- describe transformed cell and transformation
- introduce mammalian cell with plasmid encoding HCV genes and flavivirus replicon
- describe method for producing HCV structural protein or replication-competent HCV particles
- introduce system for assaying HCV particle entry into a cell
- describe HCV particle entry assay
- identify cellular proteins necessary for HCV particle entry
- identify HCV glycoproteins necessary for HCV particle entry
- identify test compounds effective at blocking HCV particle entry
- identify cellular factors involved in HCV particle release
- identify test compounds that inhibit HCV particle assembly, maturation, egress or genome packaging
- describe methods employing recombinant mammalian cell
- study contribution of HCV structural proteins to viral spreading
- study contribution of HCV non-structural proteins to viral production
- produce infectious HCV containing wild type full-length genome without adaptive mutations

## EXAMPLES

### Materials and Methods

- describe plasmid constructs
- list antibodies used
- detail cell cultures and maintenance
- outline production of HCV particles in mammalian cells
- describe transmission electron microscopy (TEM) analysis
- summarize RNA analysis and RT-qPCR
- describe infectivity assay with HCVbp
- describe entry assay with reporter system
- analyze HCV RNA in HuH-7.5 cells after infection with HCVbp
- test siRNA effect on HCVrp infectivity with reporter system
- describe transduction of HepG2 with lentivirus-hCD81
- treat BHK-WNV1 cells with antiviral drugs
- perform subtractive hybridization to identify cellular factors
- knockdown genes in BHK-WNV1 cells using siRNAs
- analyze effect of Rab1 on HCV production by BHK-WNV1 cells

### Example 2

- demonstrate flavivirus SG-replicon enhancement of HCV particle release

### Example 3

- show N-glycosylation requirement for HCV structural protein processing

### Example 4

- produce HCV particles with infectious RNA in BHK-WNV1 cells
- analyze particle morphology by transmission electron microscopy
- demonstrate infectivity of HCV particles in HuH-7.5 cells

### Example 5

- design reporter gene system for detecting HCV entry
- study HCV cell entry using BHK-WNV1 cell-produced HCV reporter particles

### Example 6

- demonstrate CD81 requirement for HCV particle entry

### Example 7

- investigate mechanism of enhanced HCV release by WNV-SG rep

### Example 8

- treat BHK-WNV1 cells with antiviral drugs
- assess inhibition of WNV SG-rep by antiviral treatments
- compare HCVbp release in treated and untreated cells
- analyze cytoplasmic membrane rearrangements
- conclude on changes in intracellular trafficking

